Compare Muller & Phipps (Ceylon) Plc with Similar Stocks
Dashboard
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -5.57% and Operating profit at -213.05% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 108.03% signifying low profitability per unit of shareholders funds
2
Flat results in Dec 25
3
Risky -
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
76.92%
0%
76.92%
6 Months
109.09%
0%
109.09%
1 Year
109.09%
0%
109.09%
2 Years
130.0%
0%
130.0%
3 Years
155.56%
0%
155.56%
4 Years
91.67%
0%
91.67%
5 Years
228.57%
0%
228.57%
Muller & Phipps (Ceylon) Plc for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-5.57%
EBIT Growth (5y)
-213.05%
EBIT to Interest (avg)
-0.21
Debt to EBITDA (avg)
1.46
Net Debt to Equity (avg)
-1.30
Sales to Capital Employed (avg)
5.22
Tax Ratio
16.51%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
31.07%
ROE (avg)
108.03%
Valuation key factors
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
NA
EV to EBIT
-0.36
EV to EBITDA
-0.37
EV to Capital Employed
-0.92
EV to Sales
0.06
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
123.98%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
123.70
147.60
-16.19%
Operating Profit (PBDIT) excl Other Income
-24.20
-14.90
-62.42%
Interest
2.90
3.60
-19.44%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-35.90
-0.60
-5,883.33%
Operating Profit Margin (Excl OI)
-201.40%
-105.90%
-9.55%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is -16.19% vs 0.68% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is -5,883.33% vs 97.89% in Sep 2025
Annual Results Snapshot (Consolidated) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
724.60
763.50
-5.09%
Operating Profit (PBDIT) excl Other Income
-79.60
74.40
-206.99%
Interest
21.70
58.00
-62.59%
Exceptional Items
-4.80
0.40
-1,300.00%
Consolidate Net Profit
-83.70
75.10
-211.45%
Operating Profit Margin (Excl OI)
-113.70%
94.40%
-20.81%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2025 is -5.09% vs 44.90% in Mar 2024
Consolidated Net Profit
YoY Growth in year ended Mar 2025 is -211.45% vs 185.05% in Mar 2024
About Muller & Phipps (Ceylon) Plc 
Muller & Phipps (Ceylon) Plc
Pharmaceuticals & Biotechnology
Muller & Phipps (Ceylon) PLC serves as the holding company of its subsidiary, Pettah Pharmacy (Pvt) Ltd. The Company's principal activity is to serve as agent representative in Sri Lanka for foreign pharmaceutical companies and operate in importing, wholesale and distribution of pharmaceuticals. Pettah Pharmacy (Private) Limited imports and sells drugs and pharmaceuticals. The Company's parent entity is E.B. Creasy & Company PLC.






